Cross Country Healthcare, Inc. (CCRN)
NASDAQ: CCRN · IEX Real-Time Price · USD
16.74
-1.16 (-6.48%)
May 2, 2024, 4:00 PM EDT - Market closed
Cross Country Healthcare Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for CCRN stock have an average target of 21.67, with a low estimate of 16 and a high estimate of 26. The average target predicts an increase of 29.45% from the current stock price of 16.74.
Analyst Consensus: Buy
* Price targets were last updated on Feb 27, 2024.
Analyst Ratings
The average analyst rating for CCRN stock from 8 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 5 | 6 | 6 | 5 | 5 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 10 | 10 | 9 | 9 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barrington Research | Barrington Research | Buy Maintains $26 → $24 | Buy | Maintains | $26 → $24 | +43.37% | Feb 27, 2024 |
| Truist Securities | Truist Securities | Hold Maintains $22 → $16 | Hold | Maintains | $22 → $16 | -4.42% | Feb 22, 2024 |
| Benchmark | Benchmark | Strong Buy Maintains $24 → $21 | Strong Buy | Maintains | $24 → $21 | +25.45% | Feb 22, 2024 |
| JMP Securities | JMP Securities | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Dec 6, 2023 |
| UBS | UBS | Hold Initiates $22 | Hold | Initiates | $22 | +31.42% | Nov 30, 2023 |
Financial Forecast
Revenue This Year
1.51B
from 2.02B
Decreased by -25.09%
Revenue Next Year
1.57B
from 1.51B
Increased by 3.97%
EPS This Year
0.95
from 2.05
Decreased by -53.54%
EPS Next Year
1.25
from 0.95
Increased by 30.79%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 1.6B | 1.7B | 1.7B |
| Avg | 1.5B | 1.6B | 1.7B |
| Low | 1.4B | 1.4B | 1.6B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -20.6% | 13.2% | 10.4% |
| Avg | -25.1% | 4.0% | 5.7% |
| Low | -31.2% | -8.9% | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 1.10 | 1.63 | 1.80 |
| Avg | 0.95 | 1.25 | 1.49 |
| Low | 0.80 | 1.00 | 1.19 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -46.2% | 70.9% | 44.1% |
| Avg | -53.5% | 30.8% | 19.5% |
| Low | -60.8% | 5.0% | -4.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.